This article was originally published in The Gray Sheet
Executive SummaryPresident and Chief Operating Officer Eric Krasnoff takes over as chairman and CEO following the July 10 death of Maurice Hardy. Executive VP Jeremy Hayward-Surry becomes president and continues to serve as treasurer, chief financial officer, and board member. Executive VP Derek Williams becomes COO and takes the position of chairman of Pall Europe
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.